A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2009
12/30/2009	EP2138484A1 Fused bicyclic heteroaryl derivatives
12/30/2009	EP2138482A1 Bicyclic heterocyclic compound
12/30/2009	EP2138178A1 Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
12/30/2009	EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria
12/30/2009	EP2138173A1 Pharmaceutical compositions comprising aminoadamantane derivatives
12/30/2009	EP2136824A1 Use of selected lactic acid bacteria for reducing atherosclerosis
12/30/2009	EP2136780A1 Use of ranolazine for the treatment of cardiovascular diseases
12/30/2009	EP1763343B1 Calcium trifluoroacetate for preparing antiangiogenetic medicaments
12/30/2009	EP1742945B1 Substituted phenylamino-pyrimidines
12/30/2009	EP1701701B1 Methods of preparing a foam comprising a sclerosing agent
12/30/2009	EP1523541B1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
12/30/2009	EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/30/2009	EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis
12/30/2009	EP1448565B1 ADENOSINE A2a RECEPTOR ANTAGONISTS
12/30/2009	EP1307108B1 Oil/fat composition
12/30/2009	EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof
12/30/2009	CN201372259Y Manufacturing system extracting chitosan of antibiotic peptide substance from maggots
12/30/2009	CN201370888Y Multifunctional medicated pad
12/30/2009	CN101613688A Von willebrand factor (vWF)-cleaving protease
12/30/2009	CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009	CN100575945C A detection method for coronary heart disease treating medicine tablet of seven ingredients
12/30/2009	CN100575492C CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof
12/30/2009	CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
12/30/2009	CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/30/2009	CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders
12/30/2009	CN100574800C Proprietary Chinese medicine for treating atherosclerosis of cardio-cerebral arteria and method for preparing the same
12/30/2009	CN100574799C Ginseng sini injection four treating cold limbs and preparing method
12/30/2009	CN100574796C Medicine for treating heart disease and preparation process thereof
12/30/2009	CN100574795C Chinese traditional medicine for treating myocarditis
12/30/2009	CN100574777C Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its production process
12/30/2009	CN100574758C Compound for treating ischemic related disease
12/30/2009	CN100574754C Preparation method of total coumarins extract from peucedanum praeruptorum dunn
12/30/2009	CN100574752C Medicine composition for preventing and curing schemic cerebrovaseular disease as well as preparation method thereof
12/30/2009	CN100574638C Compound containing DAG and the method for preparing the same
12/30/2009	CA2729604A1 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
12/30/2009	CA2729327A1 Organic compounds
12/30/2009	CA2729108A1 Organic compounds
12/30/2009	CA2729050A1 Diaryl ureas for treating heart failure
12/30/2009	CA2729048A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
12/30/2009	CA2729041A1 Diaryl urea for treating heart failure
12/30/2009	CA2728137A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009	CA2728128A1 6-substituted isoquinolines and isoquinolinones
12/30/2009	CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/30/2009	CA2728016A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009	CA2727340A1 Carboxylic acid compound
12/29/2009	US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/29/2009	US7638607 Urocortin proteins and uses thereof
12/29/2009	US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders
12/29/2009	US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/29/2009	US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound
12/29/2009	US7638524 For reducing serum cholesterol in a mammal
12/29/2009	US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc.
12/29/2009	US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
12/29/2009	US7638520 Pyrimidine compounds
12/29/2009	US7638494 G-type peptides to ameliorate atherosclerosis
12/29/2009	US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
12/29/2009	US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
12/29/2009	US7638330 Method of promoting the differentiation of staminal cells
12/29/2009	US7638328 Method for efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system, long-term propagation of hBS cells under feeder-free conditions and use of cultured hBS cells for applications in myocardial regeneration
12/29/2009	US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
12/29/2009	US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine
12/29/2009	CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/29/2009	CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/29/2009	CA2451932C Pyrrolopyrimidines as protein kinase inhibitors
12/29/2009	CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009	CA2424522C Substituted benzene derivatives or salts thereof
12/29/2009	CA2415683C Indoloquinazolinones
12/29/2009	CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009	CA2410311C Barbituric acid analogs as therapeutic agents
12/29/2009	CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009	CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
12/29/2009	CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
12/24/2009	US20090318547 Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
12/24/2009	US20090318524 Bicyclic tetrahydropyrrole compounds
12/24/2009	US20090318489 Aporphine compounds and pharmaceutical use thereof
12/24/2009	US20090318462 Protein kinase c zeta inhibition to treat vascular permeability
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318444 Tetrahydro- and dihydroquinazolinones
12/24/2009	US20090318425 Apoptosis signal-regulating kinase 1 inhibitors
12/24/2009	US20090318407 Inhibitors of protein kinases
12/24/2009	US20090318383 Compositions and methods for modulation of vascular structure and/or function
12/24/2009	US20090318365 Metastin derivatives and use thereof
12/24/2009	US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
12/24/2009	US20090317497 Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
12/24/2009	US20090317452 Transdermal patch
12/24/2009	US20090317401 Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2
12/24/2009	US20090317369 Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium
12/24/2009	US20090317367 Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
12/24/2009	DE10262084B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage
12/23/2009	WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009154944A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
12/23/2009	WO2009154766A1 Renin inhibitors and method of use thereof
12/23/2009	WO2009154741A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors
12/23/2009	WO2009154190A1 Pyridone compound
12/23/2009	WO2009154026A1 Antibody against calcified globule and use of the same
12/23/2009	WO2009153972A1 Agent for prevention of or protection against hypoxic damage comprising mirna as active ingredient

1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 1595